Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

335 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Overcoming apoptosis deficiency of melanoma-hope for new therapeutic approaches.
Eberle J, Kurbanov BM, Hossini AM, Trefzer U, Fecker LF. Eberle J, et al. Drug Resist Updat. 2007 Dec;10(6):218-34. doi: 10.1016/j.drup.2007.09.001. Epub 2007 Dec 3. Drug Resist Updat. 2007. PMID: 18054518 Review.
Protein patterns of benign and malignant human melanocytes show consistent changes in gene expression.
Eberle J, Garbe C, Kroumpouzos G, Orfanos CE. Eberle J, et al. Recent Results Cancer Res. 1995;139:123-35. doi: 10.1007/978-3-642-78771-3_9. Recent Results Cancer Res. 1995. PMID: 7597285
Identification of genes specifically regulated in human melanoma cells.
Eberle J, Garbe C, Orfanos CE. Eberle J, et al. Arch Dermatol Res. 1995;287(5):421-7. doi: 10.1007/BF00373422. Arch Dermatol Res. 1995. PMID: 7625850
P53 mutation and c-fos overexpression are associated with detection of the antigen VLA-2 in human melanoma cell lines.
Kroumpouzos G, Eberle J, Garbe C, Orfanos CE. Kroumpouzos G, et al. Among authors: eberle j. Pigment Cell Res. 1994 Oct;7(5):348-53. doi: 10.1111/j.1600-0749.1994.tb00638.x. Pigment Cell Res. 1994. PMID: 7886007
Human melanoma cell lines show little relationship between expression of pigmentation genes and pigmentary behaviour in vitro.
Eberle J, Wagner M, MacNeil S. Eberle J, et al. Pigment Cell Res. 1998 Jun;11(3):134-42. doi: 10.1111/j.1600-0749.1998.tb00723.x. Pigment Cell Res. 1998. PMID: 9730320
Desensitization of melanoma cells to autocrine TGF-beta isoforms.
Krasagakis K, Krüger-Krasagakes S, Fimmel S, Eberle J, Thölke D, von der Ohe M, Mansmann U, Orfanos CE. Krasagakis K, et al. Among authors: eberle j. J Cell Physiol. 1999 Feb;178(2):179-87. doi: 10.1002/(SICI)1097-4652(199902)178:2<179::AID-JCP7>3.0.CO;2-5. J Cell Physiol. 1999. PMID: 10048582
Downregulation of endothelin B receptor in human melanoma cell lines parallel to differentiation genes.
Eberle J, Weitmann S, Thieck O, Pech H, Paul M, Orfanos CE. Eberle J, et al. J Invest Dermatol. 1999 Jun;112(6):925-32. doi: 10.1046/j.1523-1747.1999.00598.x. J Invest Dermatol. 1999. PMID: 10383740
Resistance to CD95/Fas-induced and ceramide-mediated apoptosis of human melanoma cells is caused by a defective mitochondrial cytochrome c release.
Raisova M, Bektas M, Wieder T, Daniel P, Eberle J, Orfanos CE, Geilen CC. Raisova M, et al. Among authors: eberle j. FEBS Lett. 2000 May 4;473(1):27-32. doi: 10.1016/s0014-5793(00)01491-5. FEBS Lett. 2000. PMID: 10802053
The Bax/Bcl-2 ratio determines the susceptibility of human melanoma cells to CD95/Fas-mediated apoptosis.
Raisova M, Hossini AM, Eberle J, Riebeling C, Wieder T, Sturm I, Daniel PT, Orfanos CE, Geilen CC. Raisova M, et al. Among authors: eberle j. J Invest Dermatol. 2001 Aug;117(2):333-40. doi: 10.1046/j.0022-202x.2001.01409.x. J Invest Dermatol. 2001. PMID: 11511312
Bcl-2 overexpression prevents apoptosis induced by ceramidase inhibitors in malignant melanoma and HaCaT keratinocytes.
Raisova M, Goltz G, Bektas M, Bielawska A, Riebeling C, Hossini AM, Eberle J, Hannun YA, Orfanos CE, Geilen CC. Raisova M, et al. Among authors: eberle j. FEBS Lett. 2002 Apr 10;516(1-3):47-52. doi: 10.1016/s0014-5793(02)02472-9. FEBS Lett. 2002. PMID: 11959101
335 results
Jump to page